Decrease in the need for blood transfusions in cancer patients as a result of the use of epoetin alpha during cisplatin-containing chemotherapy;Afname van de transfusiebehoefte bij oncologiepatiënten door het gebruik van epoëtine tijdens cisplatinebevattende chemotherapie

Nederlands Tijdschrift voor Geneeskunde

Volumn 145, Issue 18, 2001, Pages 878-881

  Savonije, J H ^a   Spanier, B W M ^a   Van Groeningen, C J ^a   Giaccone, G ^a   Pinedo, H M ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; HUMAN; HYPERTENSION; SIDE EFFECT; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD TRANSFUSION; CISPLATIN; DEOXYCYTIDINE; DRUG THERAPY, COMBINATION; EPOETIN ALFA; FEMALE; HEMATINICS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; TREATMENT OUTCOME;

EID: 0035810659     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Mechanisms of abnormal erythropoiesis in malignancy
2. Decreased erythropoietin response in patients with the anemia of cancer
3. Isolation and characterization of genomic and cDNA clones of human erythropoietin
4. Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients
5. Recombinant human erythropoietin treatment in cisplatin-associated anemia: A randomized, double-blind trial with placebo
6. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmycloid malignancies during cancer chemotherapy in community oncology practice
7. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study
8. Transfusion risks and limitations
9. Gemcitabine-cisplatin: A schedule finding study
10. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy